2019 - Present
PostEra
CEO & Co-Founder
AI for drug discovery. Without the hype.
Company Highlights
- We built Proton, an end-to-end AI medicinal chemistry platform for small molecule drug discovery
- Used Proton to advance 12 medicines for diseases spanning Cancer, Obesity, Viral Infections, Polycystic Ovary Syndrome, and Infertility
- The latter two drugs made it all the way to the start of clinical trials. A picture speaks a thousands words, so here's the read life little tablets our AI helped develop for PCOS and Infertility
- Signed $1.3B of AI deals with Pfizer, Amgen, and the NIH
- Launched COVID Moonshot, the world's largest open-science effort to develop a patent-free COVID antiviral
- Grew the team to 40 people and raised $26M of venture capital